1-20 of 582
CCR Translations
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patient-derived Organoids Pharmacotyping Guides Precision Medicine for Pancreatic Cancer

Yuqing Zhang, Courtney W. Houchen, Min Li
Journal: Clinical Cancer Research
Clin Cancer Res clincanres.1083.2022.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-1083
Published: 26 May 2022
View article
PDF
Journal Articles

Trials, tribunals, and opportunities for lung cancer KRASG12C brain metastases

Anuhya Kommalapati, Aaron S. Mansfield
Journal: Clinical Cancer Research
Clin Cancer Res clincanres.1137.2022.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-1137
Published: 24 May 2022
View article
PDF
Journal Articles

All About That Ras: Novel Fusion Drives Ras Pathway Activation in Lung Cancer

Sitapriya Moorthi, Alice H. Berger
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF3.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0736
Published: 23 May 2022
View article
PDF
Journal Articles

War Against NRAS-mutant Melanoma Using Targeted Therapies Remains Challenging

Stergios J. Moschos
Journal: Clinical Cancer Research
Clin Cancer Res clincanres.1256.2022.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-1256
Published: 19 May 2022
View article
PDF
Journal Articles

Hostile Takeover: Tregs expand in IFN-γ-rich AML microenvironment

P. Brent. Ferrell, Shahram Kordasti
Journal: Clinical Cancer Research
Clin Cancer Res clincanres.1030.2022.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-1030
Published: 19 May 2022
View article
PDF
Journal Articles

Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer

Shih Yu Cindy Yang, Trevor J. Pugh, Amit M. Oza
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF3.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0336
Published: 17 May 2022
View article
PDF
Journal Articles

PD-1 inhibition - trouble for subsequent TIL therapy in patients with melanoma?

Eryn Blass, Patrick A. Ott
Journal: Clinical Cancer Research
Clin Cancer Res clincanres.0832.2022.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0832
Published: 16 May 2022
View article
PDF
Journal Articles

Revisiting Intracavitary Immunotherapy of Cancer

Fernando Aranda, Iñaki Eguren-Santamaria, Ángela Bella, Pedro Berraondo, Ignacio Melero
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (10): 1993–1995.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0201
Published: 13 May 2022
View article
PDF
Journal Articles

Standing Watch: Immune Activation and Failure in Melanoma Sentinel Lymph Nodes

Amanda W. Lund
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (10): 1996–1998.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0214
Published: 13 May 2022
View article
PDF
Journal Articles

Biomarker Development: Bedside to Bench

Grace E. Mishkin, Elise C. Kohn
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF3.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0750
Published: 12 May 2022
View article
PDF
Journal Articles

Linking Genotype to Phenotype: Bench to Bedside

Suzanne George, Monica M. Bertagnolli
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF3.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0027
Published: 09 May 2022
View article
PDF
Journal Articles

Shall We Dance: Evolving Partnerships of Targeted Therapies for AML

Alexander E. Perl, Paresh Vyas
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF3.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0279
Published: 06 May 2022
View article
PDF
Journal Articles

What's in a Name? That Which We Call Immune Cells by Any Other Name Would All Smell as Sweet

Roberto Salgado, Sherene Loi
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF2.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0783
Published: 03 May 2022
View article
PDF
Journal Articles

Neuroendocrine and Rare Tumor Advances: A New and Promising TRAIL Emerges

Dwight H. Owen, Nikolaos A. Trikalinos
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (9): 1748–1750.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0120
Published: 02 May 2022
View article
PDF
Journal Articles

Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian Cancer

Antonia Digklia, George Coukos, Krisztian Homicsko
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (9): 1745–1747.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-4592
Published: 02 May 2022
View article
PDF
Journal Articles

Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma

David H. Henry, Robert G. Maki
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF3.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0884
Published: 29 April 2022
View article
PDF
Journal Articles

Sounding the Alarm on Leiomyosarcoma Recurrence: Role of Circulating Tumor DNA

Bernd Kasper, Breelyn A. Wilky
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF2.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0738
Published: 25 April 2022
View article
PDF
Journal Articles

An Ascendant Challenge: Central Nervous System Metastases in ALK+ Lung Cancers

Yonina R. Murciano-Goroff, Guilherme Harada, Alexander Drilon
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF3.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0341
Published: 21 April 2022
View article
PDF
Journal Articles

Microenvironment Is a Key Determinant of Immune Checkpoint Inhibitor Response

Shih-Feng Cho, Kenneth C. Anderson, Yu-Tzu Tai
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1479–1481.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0015
Published: 14 April 2022
View article
PDF
Journal Articles

PARPs: All for One and One for All? Enhancing Diversity in Clinical Trials

Shibani Nicum, Sarah P. Blagden
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF3.
DOI: https://doi.org/10.1158/1078-0432.CCR-22-0442
Published: 14 April 2022
View article
PDF